Insmed, Inc. (INSM)

NASDAQ

$98.48

$-1.95

(-1.94%)

Regular Market

Insmed, Inc. (INSM) Live Price Chart

Last updated: ⁦2026-10-12 19:18:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Insmed, Inc. (INSM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $98.48, with a market capitalization of $21.97B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $90.39 to $212.75. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$21.97B
Open	$98.82
Day's High	$212.75
Day's Low	$2.64
Previous Close	$100.60
Volume	956.90K
Average Volume	2.59M
P/E Ratio	--
52-Week High	$212.75
52-Week Low	$90.39
Dividend Yield	--
Earnings Date	--

Insmed, Inc. (INSM) Stock Price Today

Insmed, Inc. (INSM) is currently trading at $98.48 as of 2026-10-12 19:17:00, down 2.11% ($2.13) from the previous close of $100.60

During today's regular trading session, INSM has traded between $2.64 and $212.75, with a trading volume of 956.90K shares. The current price is near the middle of today's range.

Insmed, Inc. (INSM) 7-Day Stock Price Change

Over the past seven days, Insmed, Inc. (INSM) moved from $108.59 to $98.48, representing a decline of 9.31% ($10.12).

The stock traded between $96.68 and $116.19 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 3.82 million shares, up versus the previous seven-day period, indicating higher trading activity.

INSM 52-Week Price Position

Position in Range: 6.6%

52W Low$90.39

52W High$212.75

INSM is currently trading at $98.48, placing it 6.6% of the way from its 52-week low of $90.39 to its 52-week high of $212.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Insmed, Inc. (INSM)?

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Insmed, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1664
Exchange	NASDAQ
Company Website	https://www.insmed.com

How to Buy Insmed, Inc. (INSM) Stock on MEXC

Eligible investors can buy real shares of Insmed, Inc. (INSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INSM and Place Your Order

Open the RealStocks trading page and search for INSM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Insmed, Inc. (INSM) stock price today?

Insmed, Inc. (INSM) is currently trading at $ 98.48, down 2.11% ($2.13) from the previous close of $ 100.60. Intraday prices update in real time during regular trading hours.

2.Is INSM stock going up or down today?

As of 2026-10-12 19:17:00, INSM is trading at $ 98.48, down 2.11% ($2.13) from its previous close of $ 100.60. The stock has traded between $ 2.64 and $ 212.75 during today’s regular session. Past price movements do not guarantee future results.

3.What is INSM pre-market price?

As of 2026-10-12 19:17:00, INSM is trading at $ 99.19 in pre-market trading, down 1.41% ($1.41) from the previous close of $ 100.60. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INSM after-hours price?

As of 2026-10-12 19:17:00, INSM is trading at $ 101.12 in after-hours trading, up 0.52% ($0.52) from the regular-session close of $ 100.60. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is INSM stock trading now?

INSM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INSM sit relative to its 52-week high and low?

Over the past 52 weeks, INSM has traded between a low of $ 90.39 and a high of $ 212.75. At $ 98.48, the stock is positioned 6.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Insmed, Inc. in?

Insmed, Inc. (INSM) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Insmed, Inc.'s market capitalization and where is it listed?

Insmed, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 21.97B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INSM valued in terms of P/E ratio and EPS?

INSM trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.01. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Insmed, Inc. pay a dividend?

Insmed, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.